Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like Ampc β-lactamase produced by klebsiella pneumoniae isolates from chickens in henan province, China

Genetics and Molecular Research

Volumn 11, Issue 3, 2012, Pages 3357-3364

  Hu, G Z ^a   Wu, H ^a   Liu, B G ^a   Liu, J H ^a   Pan, Y S ^a   Yuan, L ^a  

^a HENAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Ampc lactamase; Extended spectrum lactamases; Genotype; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; BETA LACTAMASE AMPC; BETA LACTAMASE SHV; CEFEPIME; CEFOTAXIME; CEFTIOFUR; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; ENROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; EXTENDED SPECTRUM CTX M 14 BETA LACTAMASE; FLORFENICOL; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; NEOMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BETA LACTAMASE AMPC GENE; CHICKEN; CHINA; CONTROLLED STUDY; ENZYME ASSAY; GENE AMPLIFICATION; GENOTYPE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 84930475042     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.September.24.1     Document Type: Article

References (25)

1. Bauernfeind A, Chong Y and Schweighart S (1989). Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17: 316-321.
2. Bradford PA (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-51.
3. Bradford PA, Urban C, Mariano N, Projan SJ, et al. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother. 41: 563-569.
4. Chen Y, Cheng J, Wang Q, Ye Y, et al. (2009). ACT-3, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China. Int. J. Antimicrob. Agents 33: 95-96.
5. Clinical and Laboratory Standards Institute (2008). Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement (M100-S16) CLSI. Wayne.
6. Clinical and Laboratory Standards Institute (2008). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals Approved Standard. 3rd edn. (M31-A3) CLSI, Wayne.
7. Coudron PE, Moland ES and Thomson KS (2000). Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38: 1791-1796.
8. Coudron PE, Hanson ND and Climo MW (2003). Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. J. Clin. Microbiol. 41: 772-777.
9. De Champs C, Sirot D, Chanal C, Bonnet R, et al. (2000). A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. The French Study Group. Antimicrob. Agents Chemother. 44: 3177-3179.
10. Doi Y and Paterson DL (2007). Detection of plasmid-mediated class C β-lactamases. Int. J. Infect. Dis. 11: 191-197.
11. Feizabadi MM, Delfani S, Raji N, Majnooni A, et al. (2010). Distribution of blaTEM, blaSHV, blaCTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafnejad Hospital, Tehran, Iran. Microb. Drug Resist. 16: 49-53.
12. Hu GZ, Chen HY, Si HB, Deng LX, et al. (2008). Phenotypic and molecular characterization of TEM-116 extended-spectrum β-lactamase produced by a Shigella fexneri clinical isolate from chickens. FEMS Microbiol. Lett. 279: 162-166.
13. Khalaf NG, Eletreby MM and Hanson ND (2009). Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect. Dis. 9: 84.
14. Ko KS, Yeom JS, Lee MY, Peck KR, et al. (2008). Clonal dissemination of extended-spectrum β-lactamase (ESBL)- producing Klebsiella pneumoniae isolates in a Korean hospital. J. Korean Med. Sci. 23: 53-60.
15. Lartigue MF, Zinsus C, Wenger A, Bille J, et al. (2007) Extended Spectrum β-Lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51: 2855-2860.
16. Lautenbach E, Strom BL, Bilker WB, Patel JB, et al. (2001). Epidemiological investigation of fuoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33: 1288-1294.
17. Lavigne JP, Bonnet R, Michaux-Charachon S, Jourdan J, et al. (2004). Post-antibiotic and post-β-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum β-lactamase-producing Gram-negative bacteria. J. Antimicrob. Chemother. 53: 616-619.
18. Papanicolaou GA, Medeiros AA and Jacoby GA (1990). Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34: 2200-2209.
19. Paterson DL and Bonomo RA (2005). Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18: 657-686.
20. Paterson DL, ulazimoglu L, Casellas JM, Ko WC, et al. (2000). Epidemiology of ciprofoxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30: 473-478.
21. Queenan AM, Foleno B, Gownley C, Wira E, et al. (2004). Effects of inoculum and β-lactamase activity in AmpC- and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J. Clin. Microbiol. 42: 269-275.
22. Sirot D (1995). Extended-spectrum plasmid-mediated β-lactamases. J. Antimicrob. Chemother. 36 Suppl A: 19-34.
23. Tenover FC, Emery SL, Spiegel CA, Bradford PA, et al. (2009). Identifcation of plasmid-mediated AmpC β-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results. J. Clin. Microbiol. 47: 294-299.
24. Winokur PL, Canton R, Casellas JM and Legakis N (2001). Variations in the prevalence of strains expressing an extended- spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacifc region. Clin. Infect. Dis. 32 Suppl 2: S94-103.
25. Yuan L, Liu JH, Hu GZ, Pan YS, et al. (2009). Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli isolates from chickens in Henan Province, China. J. Med. Microbiol. 58: 1449-1453.